3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
15
Stomach Neoplasms
11
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Rectal Neoplasms
4
Pancreatic Neoplasms
3
Neoplasms
3
Biliary Tract Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Adenocarcinoma
2
Vipoma
1
Somatostatinoma
1
Resected Liver Metastases From Colorectal Cancer
1
Recurrence
1
Quality of Life
1
Pathologic Complete Response
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Neoplasms
1
Insulinoma
1
Immunotherapy Gastrict Cancer
1
HER2-positive Gastric Cancer
1
Glucagonoma
1
Gastroesophageal Junction Adenocarcinoma
1
Gastrinoma
1
Esophageal Squamous Cell Carcinoma
1
Interventions
endostar protein
1
Oxaliplatin
1
Chemoradiotherapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Quality of Life
×
Oxaliplatin
×
Clear all
NCT03577392
2019-04-04
EXECC
Sichuan Provincial People's Hospital
Phase 2/3
Unknown
120 enrolled